An Open Label N of 1 Study to Evaluate the Safety and Efficacy of Long-Term Treatment with Ivacaftor in Combination with ALTALUREN (PTCD124) In Subjects with Nonsense Mutation Cystic Fibrosis

Grant

Date/time Interval

  • January 1, 2016 - December 31, 2017

    • Awarded By

    Total Award Amount

  • 51500.00

    • Direct Costs

  • 46818.00

    • Sponsor Award Id

  • MDBR-16-120-CF1282x

    • Contributor

  • George Solomon   Investigator  
  • Heather Hathorne   Investigator  
  • Steven Rowe   Principal Investigator